The global scale inhibitors market has witnessed significant growth over the past few years, driven by increasing demand from various industries such as oil and gas, water treatment, power ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...